Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-08-30
1995-08-22
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546118, A61K 31435
Patent
active
054440670
ABSTRACT:
This invention relates to compounds represented by formula I: ##STR1## which are agonists of angiotensin II. The invention is also concerned with the use of aforementioned agonists in the treatment of states meditated by angiotensin.
REFERENCES:
patent: 5177074 (1993-01-01), Allen et al.
M. Viswanathan et al., "Enhanced Expression of Angiotensin II at Receptors in the Skin of Rats During Experimental Wound Healing", 1992 FASEB Meeting in Anaheim, Calif., Apr. 5-9, 1992, Abstract No. 447, p. A1013.
B. Kimura et al., "Changes in Angiotensin II (All) Receptors in Skin During Wound Healing", 1992 FASEB Meeting in Anaheim, Calif., Apr. 5-9, 1992, Abstract No. 448, p. A1013.
Kivlighn Salah
Lotti Victor J.
Rivero Ralph A.
Siegl Peter K. S.
Zingaro Gloria J.
Camara Valerie J.
Daniel Mark R.
Dentz Bernard
DiPrima Joseph F.
Merck & Co. , Inc.
LandOfFree
Pharmaceutical treatment methods using angiotensin II receptor a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical treatment methods using angiotensin II receptor a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical treatment methods using angiotensin II receptor a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2142022